Sub-clinical hypothyroidism (SCH) is a condition in which Thyroid Stimulating Hormone (TSH) levels are increased, Thyroxine (T4) level is normal to low, and Triiodothyronine (T3) level is normal. Daily use of the synthetic thyroid hormone such as levothyroxine has been a standard approach to SCH. However, most modern approaches are unable to revert the condition to its normal level. Traditional approaches such as Yagya-Therapy can be an effective option in this regard. Yagya-Therapy provides pulmonary inhalation of medicinal-smoke of multiple herbs (generated through oblation in fire along with chanting of Vedic hymns), which have the potential for hormonal balance A case study is being reported wherein a patient (Male/60 years), who had been suffering from SCH since past 2 years and 4 months (pre-data), had been continuously taking allopathic medication for SCH, B12 complex and high blood pressure, and all this time TSH never became normal. The patient continued with the aforesaid medication, and took Yagya-Therapy for 3 months as an add-on therapy. Subsequently, after 4 months of completing Yagya-Therapy, post-data was recorded. Before Yagya-Therapy, TSH levels were very high, i.e. 4.79-11.82 µ/ml, which became normal (3.0 µ/ml) after the Yagya-Therapy. The earlier low levels of B12 (238-326 pg/ml) also increased to the upper side of the normal range (1034 pg/ml). Patient's other complaints such as tiredness, weakness, sleep issues were also resolved completely. Thus, the present study indicates the effectiveness of Yagya-Therapy in the treatment of SCH.
Negro R, Stagnaro-Green A. Diagnosis and management of subclinical hypothyroidism in pregnancy. BMJ. 2014;349:g4929–g4929. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25288580
Raza SA, Mahmood N. Subclinical hypothyroidism: Controversies to consensus. Indian J Endocrinol Metab. 2013;S636-42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24910826
Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol. 1995;43(1):55–68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7641412
Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009;84(1):65–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19121255
Tng EL. The debate on treating subclinical hypothyroidism. Singapore Med J. 2016;57(10):539–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27779276
Javed Z, Sathyapalan T. Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits. Ther Adv Endocrinol Metab. 2016;7(1):12–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26885359
Brahmavarchas, editor. Yagyachikitsa-yagyopathy: ek samagra evam divya chikitsa paddhati (Hindi). In: Yagya Chikitsa. Shri Vedmata Gayatri Trust, Shantikunj, Haridwar (Uttarakhand), 249411, India; 2010. p. 15–35.
Pandya P. Applied Science of Yagya for Health & Environment. Shri Vedmata Gayatri Trust, Shantikunj, Haridwar (Uttarakhand), 249411, India; 2009. 1-117. Available from: www.awgp.org
Joshi RR, Raghuvanshi M, Pandya P. Yagyopathy versus oral and iv drug administration: evaluation for pulmonary tuberculosis using compartment modeling. J Biol Syst. 2006;14(03):463–89. Available from: http://www.worldscientific.com/doi/abs/10.1142/S0218339006001891
Patel V, Mishra A, Shrivastav V. Pulmonary inhalation of medicinal smokes– an aspect of yagya therapy: an effective therapeutic application and efficient drug delivery model of multiple herbs. In: National Medicinal Plants Board (Ministry of AYUSH, Govt Of India) sponsored National conference on Recent Advances in Ayurvedic Herbal Medicine -Dehradun. 2017. 16th Sept.
Mohagheghzadeh A, Faridi P, Shams-Ardakani M, Ghasemi Y. Medicinal smokes. J Ethnopharmacol. 2006;108(2):161–84.
Raghuvanshi M, Pandya P, Joshi RR. Yagyopathic Herbal Treatment of Pulmonary Tuberculosis Symptoms: A Clinical Trial. Altern Complement Ther. 2004;10(2):101–5. Available from: http://www.liebertonline.com/doi/abs/10.1089/107628004773933352
Raghuvanshi M, Pandya P, Joshi RR. In-vitro Testing Of An Ethnobotanical Inhalation Therapy Against Pulmonary Tuberculosis. Phytotherapie. 2009;7(5):243–9.
Sharma S. Yagya Chikitsa Dwara Manasik Swasthya Par Padane Vale Prabhav Ka Adhyayan (Hindi) (Dissertation). Dev Sanskriti Vishwavidyalaya, Shantikunj, Haridwar, Uttarakhand, India; 2009.
Sharma P, Khokhar CP, Manchanda SC, Sharma N. Yagya Therapy for Managing Inferiority & Insecurity feeling of HIV + / AIDS Patients. Dev Sanskriti Interdiscip Int J. 2012;01:70–7.
Mishra A, Batham L, Shrivastava V. Yagya Therapy as supportive care in cancer patients improved quality of life: Case studies. Interdiscip J Yagya Res. 2018;1(1):26–33.
Jagmeet Kaur, Milan C. Kanchnar guggulu and varunadi kashaya in hypothyroidism - a case study. Vol. 2, International Journal of Ayurveda and Pharma Research. 2014;2(2):09-12. Available from: https://ijapr.in/index.php/ijapr/article/view/274
Panda S, Kar A. Changes in thyroid hormone concentrations after administration of ashwagandha root extract to adult male mice. J Pharm Pharmacol. 1998;50(9):1065–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9811169
Brahmavarchas, editor. Yagya Chikitsa. 1st ed. Shri Vedmata Gayatri Trust, Shantikunj, Haridwar (Uttarakhand), 249411, India; 2010;1-368.
Vedmurti Taponishtha Pt. Shriram Sharma Acharya. Sankshipt Gayatri hawan vidhi (Hindi). Revision. Yug nirman yojana vistar trust, Gayatri Tapobhumi, Mathura; 2012:1-49.
Sharma P. Dravyaguna Vijnana - Volume II (Hindi). Chaukhambha Bharati Academy, Varanasi, Uttar Pradesh, India; 2001.
Panthi S, Gao T. Diagnosis and management of primary hypothyroidism in Traditional Chinese Medicine (TCM) and Traditional Indian Medicine (Ayurveda). Int J Clin Endocrinol Metab. 2015;1(1):009-012.
Brahmavarchas, editor. Yagya se rog-nivaran evam bal-samvarddhan ke do labh. In: Yagya- ek samagra upchar-prakriya (Pt Shriram Sharma Acharya Vangmay No 25). Akhand Jyoti Sansthan, Mathura-281003; 1994. p. 1–12.6. Available from: www.literature.awgp.org
Pandya NT, Jani P, Vanza J, Tandel H. Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension. Colloids Surfaces B Biointerfaces. 2018 May 1;165:37–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29453084
This work is licensed under a Creative Commons Attribution 4.0 International License.